GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-0.14-0.14-0.58-0.61
Low Estimate-0.18-0.18-0.75-0.65
High Estimate-0.1-0.1-0.42-0.58
Year Ago EPS-0.11-0.07-0.38-0.58
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.12-0.09-0.08-0.14
EPS Actual-0.11-0.07-0.08-0.2
Difference0.010.020-0.06
Surprise %8.30%22.20%0.00%-42.90%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.14-0.14-0.58-0.61
7 Days Ago-0.14-0.14-0.58-0.61
30 Days Ago-0.13-0.14-0.58-0.61
60 Days Ago-0.13-0.14-0.58-0.55
90 Days Ago-0.14-0.14-0.58-0.55
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.-27.30%N/AN/A0.02
Next Qtr.-100.00%N/AN/A0.04
Current Year-52.60%N/AN/A0.05
Next Year-5.20%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A